Infliximab and adalimumab, unlike ustekinumab, increase serum KL‐6 levels in Japanese patients with psoriasis
K. Yanaba,Y. Umezawa,Reiko Sakakihara,M. Chiba,T. Ito,Sota Kikuchi,O. Fukuchi,A. Asahina,H. Saeki,H. Nakagawa
DOI: https://doi.org/10.1111/1346-8138.12918
2015-08-01
Abstract:thema began to improve after 4 months, and disappeared for 6 months (Fig. 1d). Morbihan disease is characterized by persistent lymphedema on the upper half of the face and regarded as a late-stage complication of rosacea. The characteristic features are chronic course, typical clinical manifestations, lack of specific laboratory and histological findings, and refractoriness to therapeutic measures. The diagnosis is made based on the combination of clinical and histopathological findings, including dilated blood vessels, perifollicular fibrosis, perivascular and perifollicular lymphatic infiltration, and, rarely, an increased number of mast cells. We diagnosed our case with Morbihan disease from the characteristic clinical presentation and histopathological findings. There is no established guideline or satisfactory treatments for Morbihan disease. Many therapeutic options, including oral corticosteroids, tetracyclines, ketotifen, tranilast and antimycobacterium drugs, which are used alone or in combination with others, have been reported. However, clinical response with these therapies has been inadequate. Although long-term use of oral isotretinoin has been recently proposed as an effective treatment, isotretinoin is not available in Japan. We previously reported a case of Morbihan disease with massive mast cell infiltration treated successfully with longterm use of minocycline (100 mg/day for 4 months), in which we hypothesized that the treatment response was associated with the degree of mast cell infiltration. Although increased mast cell infiltration is one of the histological features, it is not found in all cases. Tetracycline has been described as suppressing cytokine production of mast cells in vitro. This is the second report of Morbihan disease with mast cell infiltration successfully treated with long-term use of minocycline. Pitting edema remained in the previous case probably due to the delay of the initiation of minocycline treatment; however, the present case achieved a significant improvement without leaving pitting edema. Although further investigation is needed, the present case is compatible with our speculation that the long-term use of tetracycline is effective in cases with increased mast cell infiltration.